WebDisclosure WebDisclosure
Basculer en Français
10900 Companies
237596 Keywords
166538 Articles
127635 Press releases
Headlines Articles Press releases GBSB Global Business School Remove
  1. Home
  2. Companies
  3. GBSB Global Business School
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/21/2024 at 09:35, 2 years 5 months ago

    Dr. Wiktor Patena Takes Helm at GBSB Global Business School

    Higher Education Educational Innovation GBSB Global Business School Dr. Wiktor Patena International Accreditation
  • BRIEF

    published on 03/21/2024 at 09:35, 2 years 5 months ago

    Le Dr Wiktor Patena prend la tête de la GBSB Global Business School

    L'enseignement Supérieur Innovation Pédagogique École De Commerce Mondiale GBSB Dr Wiktor Patena Accréditation Internationale
  • PRESS RELEASE

    published on 03/21/2024 at 09:30, 2 years 5 months ago

    Dr. Wiktor Patena assumes the executive leadership of GBSB Global, ushering in a new era of educational excellence

    GBSB Global Business School appoints Dr. Wiktor Patena as the new Head of Institution and President to lead strategic improvements and academic expansion
    GBSB Global Business School Dr. Wiktor Patena Higher Education Institution Academic Expansion Strategic Improvements
    Logo of GBSB Global Business School
Accesswire
  • Published on 08/31/2026 at 17:22, 4 hours 1 minute ago

    ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison

  • Published on 08/31/2026 at 15:50, 5 hours 33 minutes ago

    Sarama Resources - Grant of Equity Incentives

  • Published on 08/31/2026 at 15:00, 6 hours 23 minutes ago

    Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available

  • Published on 08/31/2026 at 14:30, 6 hours 53 minutes ago

    Boron One Holdings Inc. Project Update

  • Published on 08/31/2026 at 14:30, 6 hours 53 minutes ago

    While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

View all ACCESSWIRE
EQS Group
  • Published on 08/31/2026 at 19:31, 1 hour 52 minutes ago

    DEAG reports strong results for the first half of 2026

  • Published on 08/31/2026 at 19:15, 2 hours 8 minutes ago

    CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region

  • Published on 08/31/2026 at 19:00, 2 hours 23 minutes ago

    PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 24 AOUT 2026 au 28 AOUT 2026

  • Published on 08/31/2026 at 18:20, 3 hours 3 minutes ago

    CPI PROPERTY GROUP publishes financial results for the first half of 2026

  • Published on 08/31/2026 at 18:06, 3 hours 16 minutes ago

    MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026

View all EQS
Les Echos
  • Published on 08/31/2026 at 18:00, 3 hours 23 minutes ago

    MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026

  • Published on 08/31/2026 at 17:45, 3 hours 38 minutes ago

    Disclosure of transactions in own shares from August 24 to August 28, 2026

  • Published on 08/31/2026 at 17:45, 3 hours 38 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026

  • Published on 08/31/2026 at 17:45, 3 hours 38 minutes ago

    Déclaration hebdomadaire de rachat d'actions

  • Published on 08/31/2026 at 17:45, 3 hours 38 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy